Clinical Trials Directory

Trials / Unknown

UnknownNCT04865874

GDT-PPV Protocol in Thoracic Surgery

Advantages of Pulse Pressure Variation (PPV) Monitoring in Thoracic Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Peri-operative fluid-therapy is extremely important in thoracic surgery, because excessive administration of fluids during one-lung ventilation is correlated to an increasing risk of postoperative respiratory complications. Therefore, current guidelines on peri-operative management of patients undergoing thoracic surgery suggest a conservative fluid management strategy, based on intra-operative fluid loss replacement and maintenance of euvolemia. Nevertheless, intra-operative fluid loss estimation and consequently the correct infusion rate adoption are quite difficult to be addressed in clinical practice, and this often prevents the euvolemia maintenance in the peri-operative period. This limit claims the necessity to adopt new methods of fluid-therapy administration in thoracic surgery; among these the most promising is the "Goal-Directed Therapy" (GDT). GDT protocols based on Stroke Volume Variation (SVV) or Pulse Pressure Variation (PPV) monitoring have been adopted successfully in major and cardiac surgery but not yet in thoracic surgery. The aim of this randomized study is to evaluate the effects of a PPV-GDT fluid management protocol versus a conservative "zero-balance" protocol on intrapulmonary gas exchanges, in patients undergoing single-lung ventilation during thoracic surgery.

Detailed description

The intra-operative fluid-therapy (using lactated Ringer) will be based on pulse pressure variation (PPV group) with a target ≤5.8% or on compensation (1:1) of urine output (zero balance group). In both groups an intraoperative background infusion of lactated Ringer at 1-2 ml/kg/h will be administered.

Conditions

Interventions

TypeNameDescription
OTHERPPV-GDTfluid-therapy based on PPV monitoring
OTHERZero-balancefluid-therapy based on urinary output balance

Timeline

Start date
2021-09-21
Primary completion
2023-05-01
Completion
2023-06-01
First posted
2021-04-29
Last updated
2022-10-10

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04865874. Inclusion in this directory is not an endorsement.

GDT-PPV Protocol in Thoracic Surgery (NCT04865874) · Clinical Trials Directory